Hachimoji DNA Just Passed a Key Test. Here Is What It Means.
💡 UC San Diego researchers showed in September 2026 that a natural bacterial enzyme can accurately transcribe hachimoji DNA, an eight-letter genetic code that doubles life's standard four-letter alphabet. The finding means the machinery inside cells can, in principle, process entirely new genetic instructions, opening a path to drugs, diagnostics, and engineered organisms not possible today.
- Life on Earth uses four DNA letters (A, T, G, C). The hachimoji system adds four synthetic ones (P, Z, B, S), doubling the alphabet to eight.
- A September 2026 Nature Communications study showed a natural E. coli enzyme can read and copy hachimoji DNA with accuracy close to natural: the P:Z pair incorporates only about two times slower than standard G:C.
- Researchers identified and partially fixed a key accuracy flaw with the synthetic letter Z - a modified version called Z* substantially reduced errors, though not to zero.
- Critical step still not solved: translating hachimoji DNA into proteins. Full use inside living cells remains ahead.
- Applications (cancer diagnostics, expanded-vocabulary drugs) are genuinely promising but years to decades away. This is foundational science, not a near-term clinical tool.
What is hachimoji DNA?
DNA encodes all of life using only four chemical letters, or nucleotide bases: A (adenine), T (thymine), G (guanine), and C (cytosine). The word "hachimoji" comes from Japanese: "hachi" means eight, "moji" means letters or characters. The system was first introduced in 2019 by chemist Steven Benner and colleagues at the Foundation for Applied Molecular Evolution. It adds four new synthetic letters to the standard four: P, Z, B, and S. These bond in two new complementary pairs, P:Z and B:S, sitting alongside natural A:T and G:C pairs.
The idea is straightforward: if four letters can encode every living thing on Earth, eight letters can encode far more, including molecular structures that nature has never produced. Think of it as doubling the vocabulary of biology itself - the way adding new letters to an alphabet lets you express concepts a smaller set of letters cannot.
What did the 2026 study actually show?
Expanding the hachimoji DNA alphabet is only useful if life's existing molecular machinery can read the new letters. That is what this study tackled. Dong Wang's team at UC San Diego used cryo-electron microscopy, imaging individual complexes at resolutions between 2.42 and 2.75 angstroms, to watch RNA polymerase (the enzyme that reads DNA and produces RNA, the first step in making any protein) interact with hachimoji DNA in real time.
The results were notable. The enzyme recognized the synthetic letters through the same biochemical and structural signals it uses for natural base pairs. The P:Z pair incorporated only about two times slower than the natural G:C pair under identical conditions. The enzyme's quality-control step, the trigger loop, which checks that the right base was added before moving on, behaved normally. No modifications to the enzyme were needed: a completely natural bacterial enzyme reading a non-natural genetic code.
The fidelity problem - and how researchers partially solved it
Not everything worked cleanly. The synthetic letter Z had a critical accuracy problem. Its chemical structure caused it to become slightly charged at normal cellular pH, because its pKa dropped to about 7.8. That charge state allowed natural guanine to pair with Z when it should not, inserting errors into the RNA copy. This is called misincorporation, and it is a serious obstacle for any practical use.
To fix this, researchers designed a modified version called Z* (Z-star). Replacing a nitro group on Z with a carboxamide and adding a fluorine atom pushed the pKa above 10, strongly disfavoring the problematic charge state. Guanine misincorporation dropped substantially. The trade-off: Z* incorporates its correct partner slightly more slowly, because the original nitro group also helped stabilize a water molecule involved in the enzyme's chemistry. The fix improved accuracy but revealed how precisely tuned natural bases are, and how much engineering their synthetic counterparts requires.
What does this mean for you?
The most direct implication is a new class of molecular tools. The research team showed that hachimoji DNA can build synthetic molecules that recognize liver cancer cells specifically - something standard four-letter DNA cannot do as precisely. The expanded chemical vocabulary lets a molecule be designed to fit targets that natural DNA simply lacks the letters to describe.
Looking further ahead, the implications run in two directions. First, more powerful diagnostics: molecules designed with expanded alphabets can potentially detect cancers or infections earlier, because they can bind with higher specificity to targets that natural DNA aptamers can only approximate. Second, safer engineered organisms: a microbe using hachimoji DNA to perform industrial chemistry cannot accidentally swap genes with natural bacteria, because the codes do not overlap. That incompatibility is a biosafety feature, not a limitation.
For medicine, there is a longer-range possibility: a new generation of aptamers (short DNA molecules that fold into precise 3D shapes to bind a target) that achieve configurations natural DNA cannot reach. This connects to the broader trajectory of biological engineering, including the approach that delivered the first mRNA flu vaccine approved in 2026: biology's molecular machinery can, in principle, be given new kinds of code to work with.
The parallel to language is real, not just a metaphor. Natural DNA is like a language with four phonemes, capable of expressing enormous complexity but constrained by what those four building blocks can combine to form. Hachimoji expands the phoneme set. What that eventually lets researchers "write" in the language of biology is still being worked out.
What hachimoji DNA cannot do yet - and where the hype runs ahead
The 2026 study solved one step: transcription, meaning DNA being read into RNA. The next step, translation (RNA being read into a protein), is not yet solved for hachimoji. Proteins are the molecules that actually do things inside cells. Until the ribosome, the cell's protein factory, can read hachimoji RNA and assemble non-natural amino acids, the expanded alphabet cannot be used to engineer entirely new protein functions inside living organisms.
There is a second limit: all the 2026 work was done in purified enzyme systems, not inside living cells. Getting it to function within a real, complete organism, competing with thousands of other cellular processes, is a separate and substantial problem. The study showed a promising mechanism. It did not show a working cell.
Press coverage tended to lead with "scientists expanded the genetic alphabet," which is accurate but implies the problem is largely solved. It is not. What changed in September 2026 is that one critical piece of cellular machinery was shown to work with expanded-alphabet DNA, and one major accuracy flaw was identified and partially corrected. That is genuine, important progress. It is not the same as having a usable platform.
What to watch for next
The milestone to follow: can the ribosome translate hachimoji RNA into proteins carrying non-natural amino acids? Research groups working on this include Benner's group at the Foundation for Applied Molecular Evolution and others in synthetic biology. If that problem is solved, the expanded alphabet will move from a chemical demonstration to a genuine engineering platform for biology.
For now, hachimoji DNA sits where most foundational science sits: a step proven, more steps ahead, potential real but not yet captured. The value of work like this, alongside earlier findings such as biological transistors built from bacteria, is in showing that life's machinery is more flexible than it looks. Each result shrinks the gap between what biology naturally does and what humans can direct it to do.
FAQ
What does hachimoji mean?
Hachimoji comes from Japanese: "hachi" means eight and "moji" means letters or characters. The name reflects the expansion of biology's standard four-letter DNA code (A, T, G, C) to eight letters by adding synthetic bases P, Z, B, and S. Chemist Steven Benner coined the term when introducing the system in 2019.
Is this the same as what CRISPR does?
No. CRISPR edits sequences written in the standard four-letter DNA alphabet, cutting and replacing existing genetic instructions. Hachimoji adds entirely new letters to the alphabet itself, so DNA can carry information with no equivalent in natural biology. The two approaches operate at completely different levels of the genetic system.
When might hachimoji DNA lead to actual medicines?
Realistically, 10 to 20 years for therapeutic applications in humans, assuming research progresses without major setbacks. Transcription works now; translation into proteins is unsolved; and full function inside living organisms is further still. Diagnostic tools that use hachimoji DNA outside of cells may arrive sooner, since they avoid the need for full cellular integration.
Could hachimoji organisms escape into nature?
The incompatibility with natural life is actually a built-in biosafety advantage. An organism using hachimoji DNA cannot exchange genetic material with natural bacteria or other organisms, because the synthetic letters do not pair with natural ones. This containment property is one reason synthetic biologists find expanded-alphabet organisms attractive for industrial and research applications.
Why do we need more than four DNA letters if they already encode all of life?
Four letters are enough to store information, but they constrain what molecular shapes DNA and RNA can fold into. More letters mean more chemical variety, which means molecules that can bind targets natural DNA cannot reach precisely, and proteins with structures that natural amino acid sequences cannot form. The expanded alphabet is about what can be built, not just what can be stored.
Source(s): Nature Communications - Structural Basis of Transcription of the Hachimoji Eight-Letter Alphabet by E. coli RNA Polymerase (2026); UC San Diego - Breakthrough Helps Expand Genetic Alphabet (2026)
About the author
Dao Huy (Lucas) is a professional translator working across English, Vietnamese, Chinese, and French, with over seven years of experience in technical, scientific, and legal translation. He follows developments at the biology-language frontier out of genuine curiosity: much like translation moves meaning across the boundaries of human languages, synthetic biology is learning to move information across the boundary of what life itself can express. The parallel between expanding a genetic alphabet and expanding what a language can say is not incidental.
If you need accurate English-Vietnamese or technical translation for scientific content, documentation, or software, Lucas offers these services at daohuy.com. Reach out for a quote.
Written by Dao Huy (Lucas), Vietnamese translator & localization specialist (EN · ZH · FR → Vietnamese). See translation services →